Prospective Cardiovascular Surveillance With ICI-Based Combination Treatment in Patients With Advanced RCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Prospective Cardiovascular Surveillance of Immune Checkpoint Inhibitor-Based Combination Therapy in Patients With Advanced Renal Cell Cancer: Data From the Phase III JAVELIN Renal 101 Trial
J. Clin. Oncol 2022 Mar 03;[EPub Ahead of Print], BI Rini, JJ Moslehi, M Bonaca, M Schmidinger, L Albiges, TK Choueiri, RJ Motzer, MB Atkins, J Haanen, M Mariani, J Wang, S Hariharan, J LarkinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.